Forte Biosciences, Inc.

8-K Entered a material agreement; Regulation FD disclosure Jul 27, 2026 8-K Regulation FD disclosure; Other events Jul 9, 2026 8-K Director or officer change; Shareholder vote results Jun 2, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Entered a material agreement; Regulation FD disclosure; Other events Apr 9, 2026 8-K Results of operations (earnings release) Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Other events Aug 14, 2025 8-K Entered a material agreement; Other events Jun 25, 2025 8-K Regulation FD disclosure; Other events Jun 23, 2025 8-K Shareholder vote results May 30, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Other events Apr 18, 2025 8-K Results of operations (earnings release) Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Director or officer change; Shareholder vote results Jan 24, 2025 8-K Other events Dec 3, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Director or officer change; Other events Sep 20, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events Aug 30, 2024 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure Aug 22, 2024 8-K Results of operations (earnings release); Other events Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement; Other events Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release); Other events May 13, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 18, 2024 8-K Results of operations (earnings release); Other events Mar 18, 2024 8-K/A Shareholder vote results Feb 16, 2024 8-K Changed accountants Dec 8, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K/A Shareholder vote results Sep 26, 2023